Hypoxic response elements control expression of human vascular endothelial growth factor165 genes transferred to ischemia myocardium in vivo and in vitro

Journal of Gene Medicine

Volumn 9, Issue 9, 2007, Pages 788-796

  Jiang, Bo ^a   Dong, Hongyan ^a   Zhang, Zhongming ^a   Wang, Wei ^a   Zhang, Yiqian ^a   Xu, Xiahong ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Gene control; Hypoxic responce element (HRE); Ischemic mycardium; Vascular endothelial growth factor (VEGF)

Indexed keywords

ANGIOGENIC FACTOR; MESSENGER RNA; PARVOVIRUS VECTOR; VASCULOTROPIN 165;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HEART CELL CULTURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO GENE TRANSFER; IN VIVO GENE TRANSFER; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; REOXYGENATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; UPREGULATION; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; ANOXIA; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; DEPENDOVIRUS; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, FLUORESCENCE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; RESPONSE ELEMENTS; SWINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS; SUIDAE;

EID: 34548598383     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1070     Document Type: Article

References (28)

1. Isner J. Myocardial gene therapy. Nature 2002; 415: 234-239.
2. Ylä-Herttuala S. Gene therapy for coronary heart disease. Intern Med 2001; 250: 367-368.
3. Garrett DJ, Cohen JC, Larson JE. Long term physiologic modification using rAAV in utero gene-therapy. Genet Vaccines Ther 2004; 2: 4.
4. Su H, Lu R, Kan YW. Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart. Proc Natl Acad Sci USA 2000; 97: 13801-13806.
5. Lee RJ, Springer ML, Blanco-Bose WE, Shaw R, Ursell PC, Blau HM. VEGF gene delivery to myocardium deleterious effects of unregulated expression. Circulation 2000; 102: 898-901.
6. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 1999; 77: 527-543.
7. Semenza GL. HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol 2001; 13: 167-171.
8. 2-regulated gene expression. FASEB 2002; 16: 1151-1162.
9. Coulet F, Nadaud S, Agrapart M, Soubrier F. Identification of hypoxia-response element in the human endothelial nitric-oxide synthase gene promoter. Biol Chem 2003; 278: 46230-46240.
10. Ruan H, Su H, Hu L, Lamborn KR, Kan YW, deen DF. A hypoxia-regulated adeno-associated virus vector for cancer-specific gene therapy. Neoplasia 2001; 3: 255-263.
11. Li GL, Wang RZ, Wang X, et al. Production and purification of helper free recombinant adeno-associated virus 2. Chin Med J 2003; 83: 1255-1258.
12. Simons M. Angiogenesis: where do we stand now? Circulation 2005; 111: 1556-1566.
13. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 2005; 115: 572-583.
14. Khurana R, Simons M, Martin JF, Zachary IC. Role of angiogenesis in cardiovascular disease: a critical appraisal. Circulation 2005; 112: 1813-1824.
15. Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease: part I. Angiogenic cytokines. Circulation 2004; 109: 2487-2491.
16. Henry TD, Annex BH, McKendall GR. The VIVA trail: VEGF in ischemia forvascularAngiogenesis. Circulation 2003; 107: 1359.
17. Su H, Arakawa-Hoyt J, Kan YW. Adeno-associated viral vector-mediated hypoxia response element-regulated gene expression in mouse ischemic heart model Proc Nad Acad Sci U S A 2002; 99: 9480-9485.
18. Blau HM, Rossi FM. Tet B or not Tet B: advances in tetracycline-inducible gene expression. Proc Natl Acad Sci USA 1999; 96: 797-799.
19. Rossi FM, Guicherit OM, Spicher A, et al. Tetracycline-regulatable factors with distinct dimerization domains allow reversible growth inhibition by p16. Nat Genet 1998; 20: 389-393.
20. Huang LE, Bunn HF. Hypoxia-inducible factor and its biomedical relevance. Biol Chem 2003; 278: 19575-19578.
21. Rebar EJ, Huang Y, Hickey R, Nath AK, Meoli D, Nath S. Induction of angiogenesis in a mouse model using engineered transcription factors. Nat Med 2002; 8: 1427-1432.
22. Loboda A, Jazwa A, Wegiel B, Jozkowicz A, Dulak J. Heme oxygenase-1-dependent and -independent regulation of angiogenic genes expression: effect of cobalt protoporphyrin and cobalt chloride of vegf and il-8 synthesis in human microvascular endothelial cells. Cell Mol Biol 2006; 51: 347-355.
23. Springer ML, Chen AS, Kraft PE, Bednarski M, Blau HM. VEGF gene delivery to muscle: potential role for vasculogenesis in adults. Mol Cells 1998; 2: 549-558.
24. Schwarz ER, Speakman MT, Patterson M, et al. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat - angiogenesis and angioma formation. Am. Coll Cardiol 2000; 35: 1323-1330.
25. Jeong CH, Lee YM, Choi KS, et al. Hypoxia-responsive element-mediated soluble Tie2 vector exhibits an anti-angiogenic activity in vitro under hypoxic condition. Int Oncol 2005; 26: 211-216.
26. Olenyuk BZ, Zhang G, Klco JM, Nickols NG, Kaelin WG Jr, Dervan B. Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist. Proc Nad Acad Sci USA 2004; 101: 16768-16773.
27. Shibata T, Giaccia AJ, Brown JM. Hypoxia-inducible regulation of a prodrug activating enzyme for tumor-specic gene therapy. Neoplasia 2002; 4: 40-48.
28. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 1999; 15: 551-578.